The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Periphery and brain, innate and adaptive immunity in Parkinson’s disease
Open accessAbstract
Parkinson’s disease (PD) is a neurodegenerative disorder where alpha-synuclein plays a central role in the death and dysfunction of neurons, both, in central, as well as in the peripheral nervous system. Besides the neuronal events observed in patients, PD also includes a significant immune component. It is suggested that the PD-associated immune response will have consequences on neuronal health, thus opening immunomodulation as a potential therapeutic strategy in PD. The immune changes during the disease occur in the brain, involving microglia, but also in the periphery with changes in cells of the innate immune system, particularly monocytes, as well as those of adaptive immunity, such as T-cells. This realization arises from multiple patient studies, but also from data in animal models of the disease, providing strong evidence for innate and adaptive immune system crosstalk in the central nervous system and periphery in PD. Here we review the data showing that alpha-synuclein plays a crucial role in the activation of the innate and adaptive immune system. We will also describe the studies suggesting that inflammation in PD includes early changes in innate and adaptive immune cells that develop dynamically through time during disease, contributing to neuronal degeneration and symptomatology in patients. This novel finding has contributed to the definition of PD as a multisystem disease that should be approached in a more integratory manner rather than a brain-focused classical approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
El‐Agnaf, O. M. A., Overk, C., Rockenstein, E. M., Mante, M., Florio, J. B., Adame, A., Vaikath, N. N., Majbour, N. K., Lee, S., Kim, C., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.05.002 · Cited by 88
RetractedGut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Monitoring of Blood Vessels and Tissues by a Population of Monocytes with Patrolling Behavior
Auffray, C., Fogg, D., Garfa, M., Elain, G., Join-Lambert, O., Kayal, S., Sarnacki, S., Cumano, A., Lauvau, G., & Geissmann, F. (2007) · Science · doi:10.1126/science.1142883 · Cited by 1,973
Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein
Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2002) · Neuron · doi:10.1016/s0896-6273(02)00682-7 · Cited by 1,266
Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
Yun, S. P., Kam, T.-I., Panicker, N., Kim, S., Oh, Y., Park, J.-S., Kwon, S.-H., Park, Y. J., Karuppagounder, S. S., Park, H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0051-5 · Cited by 1,123
Wong, K. L., Tai, J. J.-Y., Wong, W.-C., Han, H., Sem, X., Yeap, W.-H., Kourilsky, P., & Wong, S.-C. (2011) · Blood · doi:10.1182/blood-2010-12-326355 · Cited by 1,101
The fate and lifespan of human monocyte subsets in steady state and systemic inflammation
Patel, A. A., Zhang, Y., Fullerton, J. N., Boelen, L., Rongvaux, A., Maini, A. A., Bigley, V., Flavell, R. A., Gilroy, D. W., Asquith, B., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20170355 · Cited by 946
Luk, K. C., Song, C., O'Brien, P., Stieber, A., Branch, J. R., Brunden, K. R., Trojanowski, J. Q., & Lee, V. M.-Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908005106 · Cited by 938
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
Gordon, R., Albornoz, E. A., Christie, D. C., Langley, M. R., Kumar, V., Mantovani, S., Robertson, A. A. B., Butler, M. S., Rowe, D. B., O’Neill, L. A., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah4066 · Cited by 897
Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases
Kapellos, T. S., Bonaguro, L., Gemünd, I., Reusch, N., Saglam, A., Hinkley, E. R., & Schultze, J. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02035 · Cited by 890
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866
Kim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856
McCoy, M. K., & Tansey, M. G. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-45 · Cited by 847
Microglial activation and dopamine terminal loss in early Parkinson's disease
Ouchi, Y., Yoshikawa, E., Sekine, Y., Futatsubashi, M., Kanno, T., Ogusu, T., & Torizuka, T. (2005) · Annals of Neurology · doi:10.1002/ana.20338 · Cited by 843
Vagotomy and subsequent risk of Parkinson's disease
Svensson, E., Horváth‐Puhó, E., Thomsen, R. W., Djurhuus, J. C., Pedersen, L., Borghammer, P., & Sørensen, H. T. (2015) · Annals of Neurology · doi:10.1002/ana.24448 · Cited by 806
Blum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801
Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates
Lee, H.-J., Patel, S., & Lee, S.-J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0692-05.2005 · Cited by 797
Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791 · cited 1×
“Accordingly, microgliosis has been observed in postmortem brains from PD patients in areas where neuronal death is not significantly found [90], which is also confirmed by in vivo PET imaging [61, 132] using PK11195, a ligand of the peripheral benzodiazepine receptor/TSPO (upregulated on activated microglia and other…”
BackgroundNeuronal ‘On’ and ‘Off’ signals control microglia
Biber, K., Neumann, H., Inoue, K., & Boddeke, H. W. G. M. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.08.007 · Cited by 787
Hamza, T. H., Zabetian, C. P., Tenesa, A., Laederach, A., Montimurro, J., Yearout, D., Kay, D. M., Doheny, K. F., Paschall, J., Pugh, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.642 · Cited by 784
Brain-first versus body-first Parkinson’s disease: a multimodal imaging case-control study
Horsager, J., Andersen, K. B., Knudsen, K., Skjærbæk, C., Fedorova, T. D., Okkels, N., Schaeffer, E., Bonkat, S. K., Geday, J., Otto, M., et al. (2020) · Brain · doi:10.1093/brain/awaa238 · Cited by 782
Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia
Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., Wenning, G. K., & Stefanova, N. (2013) · Glia · doi:10.1002/glia.22437 · Cited by 697
(2007) · YUHSpace (Yonsei University Medical Library) · doi:10.1016/s1474 · Cited by 641
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
Houser, M. C., & Tansey, M. G. (2017) · npj Parkinson's Disease · doi:10.1038/s41531-016-0002-0 · Cited by 588
Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies
Codolo, G., Plotegher, N., Pozzobon, T., Brucale, M., Tessari, I., Bubacco, L., & de Bernard, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055375 · Cited by 585
The link between the GBA gene and parkinsonism
Sidransky, E., & Lopez, G. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70190-4 · Cited by 583
Qin, X.-Y., Zhang, S.-P., Cao, C., Loh, Y. P., & Cheng, Y. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2742 · Cited by 554
Heintz‐Buschart, A., Pandey, U., Wicke, T., Sixel‐Döring, F., Janzen, A., Sittig‐Wiegand, E., Trenkwalder, C., Oertel, W. H., Mollenhauer, B., & Wilmes, P. (2018) · Movement Disorders · doi:10.1002/mds.27105 · Cited by 554
Machado-Santos, J., Saji, E., Tröscher, A. R., Paunovic, M., Liblau, R., Gabriely, G., Bien, C. G., Bauer, J., & Lassmann, H. (2018) · Brain · doi:10.1093/brain/awy151 · Cited by 548
Peripheral cytokines profile in parkinson’s disease
Reale, M., Iarlori, C., Thomas, A., Gambi, D., Perfetti, B., Di Nicola, M., & Onofrj, M. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.07.003 · Cited by 547
Microglial exosomes facilitate α-synuclein transmission in Parkinson’s disease
Guo, M., Wang, J., Zhao, Y., Feng, Y., Han, S., Dong, Q., Cui, M., & Tieu, K. (2020) · Brain · doi:10.1093/brain/awaa090 · Cited by 522
Synuclein activates microglia in a model of Parkinson's disease
Su, X., Maguire-Zeiss, K. A., Giuliano, R., Prifti, L., Venkatesh, K., & Federoff, H. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.006 · Cited by 474
LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
Moehle, M. S., Webber, P. J., Tse, T., Sukar, N., Standaert, D. G., DeSilva, T. M., Cowell, R. M., & West, A. B. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5601-11.2012 · Cited by 463
Dysbiosis of gut microbiota and microbial metabolites in Parkinson's disease
Sun, M.-F., & Shen, Y.-Q. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.04.004 · Cited by 445
Neuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration
Gao, H.-M., Kotzbauer, P. T., Uryu, K., Leight, S., Trojanowski, J. Q., & Lee, V. M.-Y. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0143-07.2008 · Cited by 436
Glia: Initiators and progressors of pathology in Parkinson's disease
Halliday, G. M., & Stevens, C. H. (2011) · Movement Disorders · doi:10.1002/mds.23455 · Cited by 424
Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis
Borghammer, P., & Van Den Berge, N. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191721 · Cited by 419
LRRK2 Is Involved in the IFN-γ Response and Host Response to Pathogens
Gardet, A., Benita, Y., Li, C., Sands, B. E., Ballester, I., Stevens, C., Korzenik, J. R., Rioux, J. D., Daly, M. J., Xavier, R. J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000548 · Cited by 415
Croisier, E., Moran, L. B., Dexter, D. T., Pearce, R. K., & Graeber, M. B. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-14 · Cited by 414
Harms, A. S., Cao, S., Rowse, A. L., Thome, A. D., Li, X., Mangieri, L. R., Cron, R. Q., Shacka, J. J., Raman, C., & Standaert, D. G. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5610-12.2013 · Cited by 406
Self-citationGut-seeded α-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice
Challis, C., Hori, A., Sampson, T. R., Yoo, B. B., Challis, R. C., Hamilton, A. M., Mazmanian, S. K., Volpicelli-Daley, L. A., & Gradinaru, V. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0589-7 · Cited by 405
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
Lindestam Arlehamn, C. S., Dhanwani, R., Pham, J., Kuan, R., Frazier, A., Rezende Dutra, J., Phillips, E., Mallal, S., Roederer, M., Marder, K. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15626-w · Cited by 386
Peter, I., Dubinsky, M., Bressman, S., Park, A., Lu, C., Chen, N., & Wang, A. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0605 · Cited by 386
Mazzulli, J. R., Zunke, F., Isacson, O., Studer, L., & Krainc, D. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520335113 · Cited by 386
Theodore, S., Cao, S., McLean, P. J., & Standaert, D. G. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818e5e99 · Cited by 367
Chen, Z., Li, G., & Liu, J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104700 · Cited by 363
Gao, H.-M., Zhang, F., Zhou, H., Kam, W., Wilson, B., & Hong, J.-S. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1003013 · Cited by 355
A possible role for humoral immunity in the pathogenesis of Parkinson's disease
Orr, C. F., Rowe, D. B., Mizuno, Y., Mori, H., & Halliday, G. M. (2005) · Brain · doi:10.1093/brain/awh625 · Cited by 350
Clearance and deposition of extracellular α-synuclein aggregates in microglia
Lee, H.-J., Suk, J.-E., Bae, E.-J., & Lee, S.-J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.045 · Cited by 343
B cells in autoimmune and neurodegenerative central nervous system diseases
Sabatino, J. J., Pröbstel, A.-K., & Zamvil, S. S. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0233-2 · Cited by 343
Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission
Bae, E.-J., Lee, H.-J., Rockenstein, E., Ho, D.-H., Park, E.-B., Yang, N.-Y., Desplats, P., Masliah, E., & Lee, S.-J. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1292-12.2012 · Cited by 339
MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration
Cebrián, C., Zucca, F. A., Mauri, P., Steinbeck, J. A., Studer, L., Scherzer, C. R., Kanter, E., Budhu, S., Mandelbaum, J., Vonsattel, J. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms4633 · Cited by 338
Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson's disease
Sommer, A., Marxreiter, F., Krach, F., Fadler, T., Grosch, J., Maroni, M., Graef, D., Eberhardt, E., Riemenschneider, M. J., Yeo, G. W., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.06.015 · Cited by 332
CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease
Saunders, J. A. H., Estes, K. A., Kosloski, L. M., Allen, H. E., Dempsey, K. M., Torres-Russotto, D. R., Meza, J. L., Santamaria, P. M., Bertoni, J. M., Murman, D. L., et al. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9402-z · Cited by 323
Sardi, S. P., Clarke, J., Kinnecom, C., Tamsett, T. J., Li, L., Stanek, L. M., Passini, M. A., Grabowski, G. A., Schlossmacher, M. G., Sidman, R. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108197108 · Cited by 319
Triggers, Facilitators, and Aggravators: Redefining Parkinson’s Disease Pathogenesis
Johnson, M. E., Stecher, B., Labrie, V., Brundin, L., & Brundin, P. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2018.09.007 · Cited by 310
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE‐PD)
Williams‐Gray, C. H., Wijeyekoon, R., Yarnall, A. J., Lawson, R. A., Breen, D. P., Evans, J. R., Cummins, G. A., Duncan, G. W., Khoo, T. K., Burn, D. J., et al. (2016) · Movement Disorders · doi:10.1002/mds.26563 · Cited by 304
Daniele, S. G., Béraud, D., Davenport, C., Cheng, K., Yin, H., & Maguire-Zeiss, K. A. (2015) · Science Signaling · doi:10.1126/scisignal.2005965 · Cited by 303
Cullen, V., Sardi, S. P., Ng, J., Xu, Y., Sun, Y., Tomlinson, J. J., Kolodziej, P., Kahn, I., Saftig, P., Woulfe, J., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22400 · Cited by 303
Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients
Grozdanov, V., Bliederhaeuser, C., Ruf, W. P., Roth, V., Fundel-Clemens, K., Zondler, L., Brenner, D., Martin-Villalba, A., Hengerer, B., Kassubek, J., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1345-4 · Cited by 295
Freeman, D., Cedillos, R., Choyke, S., Lukic, Z., McGuire, K., Marvin, S., Burrage, A. M., Sudholt, S., Rana, A., O'Connor, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062143 · Cited by 289
Microglial phenotypes in Parkinson’s disease and animal models of the disease
Joers, V., Tansey, M. G., Mulas, G., & Carta, A. R. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.006 · Cited by 285
Tan, T. Z., Miow, Q. H., Huang, R. Y., Wong, M. K., Ye, J., Lau, J. A., Wu, M. C., Bin Abdul Hadi, L. H., Soong, R., Choolani, M., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201823 · Cited by 281
Liu, Z., Bryant, N., Kumaran, R., Beilina, A., Abeliovich, A., Cookson, M. R., & West, A. B. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddx410 · Cited by 278
Kustrimovic, N., Comi, C., Magistrelli, L., Rasini, E., Legnaro, M., Bombelli, R., Aleksic, I., Blandini, F., Minafra, B., Riboldazzi, G., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1248-8 · Cited by 278
Microglia, Amyloid, and Glucose Metabolism in Parkinson’s Disease with and without Dementia
Edison, P., Ahmed, I., Fan, Z., Hinz, R., Gelosa, G., Ray Chaudhuri, K., Walker, Z., Turkheimer, F. E., & Brooks, D. J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.255 · Cited by 274
Wang, W., Nguyen, L. T. T., Burlak, C., Chegini, F., Guo, F., Chataway, T., Ju, S., Fisher, O. S., Miller, D. W., Datta, D., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610099113 · Cited by 270
Sanchez-Guajardo, V., Febbraro, F., Kirik, D., & Romero-Ramos, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008784 · Cited by 256
Self-citationDoorn, K. J., Moors, T., Drukarch, B., van de Berg, W. D., Lucassen, P. J., & van Dam, A.-M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0090-1 · Cited by 254
Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia
Panicker, N., Sarkar, S., Harischandra, D. S., Neal, M., Kam, T.-I., Jin, H., Saminathan, H., Langley, M., Charli, A., Samidurai, M., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20182191 · Cited by 254
Caudo‐rostral brain spreading of α‐synuclein through vagal connections
Ulusoy, A., Rusconi, R., Pérez‐Revuelta, B. I., Musgrove, R. E., Helwig, M., Winzen‐Reichert, B., & Monte, D. A. D. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302475 · Cited by 250
Watson, M. B., Richter, F., Lee, S. K., Gabby, L., Wu, J., Masliah, E., Effros, R. B., & Chesselet, M.-F. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.025 · Cited by 241
Harms, A. S., Thome, A. D., Yan, Z., Schonhoff, A. M., Williams, G. P., Li, X., Liu, Y., Qin, H., Benveniste, E. N., & Standaert, D. G. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.11.010 · Cited by 236
Self-citationSanchez-Guajardo, V., Barnum, C. J., Tansey, M. G., & Romero-Ramos, M. (2013) · ASN Neuro · doi:10.1042/an20120066 · Cited by 236
Self-citationAnimal models of α-synucleinopathy for Parkinson disease drug development
Koprich, J. B., Kalia, L. V., & Brotchie, J. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.75 · Cited by 233
Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease
George, S., Rey, N. L., Tyson, T., Esquibel, C., Meyerdirk, L., Schulz, E., Pierce, S., Burmeister, A. R., Madaj, Z., Steiner, J. A., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0335-3 · Cited by 229
Fan, Z., Pan, Y.-T., Zhang, Z.-Y., Yang, H., Yu, S.-Y., Zheng, Y., Ma, J.-H., & Wang, X.-M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1670-6 · Cited by 228
α-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia
Klegeris, A., Pelech, S., Giasson, B. I., Maguire, J., Zhang, H., McGeer, E. G., & McGeer, P. L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.11.013 · Cited by 227
Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy
Schapansky, J., Nardozzi, J. D., Felizia, F., & LaVoie, M. J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu138 · Cited by 226
Microglia Response During Parkinson’s Disease: Alpha-Synuclein Intervention
Ferreira, S. A., & Romero-Ramos, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00247 · Cited by 216
Self-citationStokholm, M. G., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Borghammer, P., Santamaria, J., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30173-4 · Cited by 209
Ho, P. W.-L., Leung, C.-T., Liu, H., Pang, S. Y.-Y., Lam, C. S.-C., Xian, J., Li, L., Kung, M. H.-W., Ramsden, D. B., & Ho, S.-L. (2020) · Autophagy · doi:10.1080/15548627.2019.1603545 · Cited by 207
Tong, J., Wong, H., Guttman, M., Ang, L. C., Forno, L. S., Shimadzu, M., Rajput, A. H., Muenter, M. D., Kish, S. J., Hornykiewicz, O., et al. (2010) · Brain · doi:10.1093/brain/awp282 · Cited by 206
Hansson, O., Hall, S., Öhrfelt, A., Zetterberg, H., Blennow, K., Minthon, L., Nägga, K., Londos, E., Varghese, S., Majbour, N. K., et al. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt255 · Cited by 205
Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
Duffy, M. F., Collier, T. J., Patterson, J. R., Kemp, C. J., Luk, K. C., Tansey, M. G., Paumier, K. L., Kanaan, N. M., Fischer, D. L., Polinski, N. K., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1171-z · Cited by 197
Mollenhauer, B., Zimmermann, J., Sixel‐Döring, F., Focke, N. K., Wicke, T., Ebentheuer, J., Schaumburg, M., Lang, E., Friede, T., Trenkwalder, C., et al. (2019) · Movement Disorders · doi:10.1002/mds.27492 · Cited by 191
Association of Parkinson Disease with Structural and Regulatory Variants in the HLA Region
Wissemann, W. T., Hill-Burns, E. M., Zabetian, C. P., Factor, S. A., Patsopoulos, N., Hoglund, B., Holcomb, C., Donahue, R. J., Thomson, G., Erlich, H., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.10.009 · Cited by 189
Regulation of LRRK2 Expression Points to a Functional Role in Human Monocyte Maturation
Thévenet, J., Pescini Gobert, R., Hooft van Huijsduijnen, R., Wiessner, C., & Sagot, Y. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021519 · Cited by 189
Krashia, P., Cordella, A., Nobili, A., La Barbera, L., Federici, M., Leuti, A., Campanelli, F., Natale, G., Marino, G., Calabrese, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11928-w · Cited by 188
Ysselstein, D., Nguyen, M., Young, T. J., Severino, A., Schwake, M., Merchant, K., & Krainc, D. (2019) · Nature Communications · doi:10.1038/s41467-019-13413-w · Cited by 186
Autoantibodies to alpha‐synuclein in inherited Parkinson’s disease
Papachroni, K. K., Ninkina, N., Papapanagiotou, A., Hadjigeorgiou, G. M., Xiromerisiou, G., Papadimitriou, A., Kalofoutis, A., & Buchman, V. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04365.x · Cited by 185
Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease
Gustot, A., Gallea, J. I., Sarroukh, R., Celej, M. S., Ruysschaert, J.-M., & Raussens, V. (2015) · Biochemical Journal · doi:10.1042/bj20150617 · Cited by 184
α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration
Harms, A. S., Delic, V., Thome, A. D., Bryant, N., Liu, Z., Chandra, S., Jurkuvenaite, A., & West, A. B. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0494-9 · Cited by 181
Self-citationAge-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes
Bliederhaeuser, C., Grozdanov, V., Speidel, A., Zondler, L., Ruf, W. P., Bayer, H., Kiechle, M., Feiler, M. S., Freischmidt, A., Brenner, D., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1504-2 · Cited by 180
Brain-to-stomach transfer of α-synuclein via vagal preganglionic projections
Ulusoy, A., Phillips, R. J., Helwig, M., Klinkenberg, M., Powley, T. L., & Di Monte, D. A. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1661-y · Cited by 179
Gomez-Isla, T., Irizarry, M. C., Mariash, A., Cheung, B., Soto, O., Schrump, S., Sondel, J., Kotilinek, L., Day, J., Schwarzschild, M. A., et al. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00091-x · Cited by 178
Wang, S., Chu, C., Stewart, T., Ginghină, C., Wang, Y., Nie, H., Guo, M., Wilson, B. C., Hong, J., & Zhang, J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417883112 · Cited by 174
LRRK2 regulation of immune-pathways and inflammatory disease
Wallings, R. L., & Tansey, M. G. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180463 · Cited by 173
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease
Chahine, L. M., Beach, T. G., Brumm, M. C., Adler, C. H., Coffey, C. S., Mosovsky, S., Caspell‐Garcia, C., Serrano, G. E., Muñoz, D. G., White, C. L., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010404 · Cited by 173
Hall, S., Janelidze, S., Surova, Y., Widner, H., Zetterberg, H., & Hansson, O. (2018) · Scientific Reports · doi:10.1038/s41598-018-31517-z · Cited by 168
Park, J., Paik, S. R., Jou, I., & Park, S. M. (2008) · Glia · doi:10.1002/glia.20691 · Cited by 165
Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells
Garretti, F., Agalliu, D., Lindestam Arlehamn, C. S., Sette, A., & Sulzer, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00303 · Cited by 162
Increased Immune Activation by Pathologic α‐Synuclein in Parkinson's Disease
Grozdanov, V., Bousset, L., Hoffmeister, M., Bliederhaeuser, C., Meier, C., Madiona, K., Pieri, L., Kiechle, M., McLean, P. J., Kassubek, J., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25557 · Cited by 161
Hoenen, C., Gustin, A., Birck, C., Kirchmeyer, M., Beaume, N., Felten, P., Grandbarbe, L., Heuschling, P., & Heurtaux, T. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162717 · Cited by 159
Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages
Aflaki, E., Moaven, N., Borger, D. K., Lopez, G., Westbroek, W., Chae, J. J., Marugan, J., Patnaik, S., Maniwang, E., Gonzalez, A. N., et al. (2016) · Aging Cell · doi:10.1111/acel.12409 · Cited by 158
Essential Neuroscience in Immunology
Chavan, S. S., & Tracey, K. J. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601613 · Cited by 158
Kim, C., Spencer, B., Rockenstein, E., Yamakado, H., Mante, M., Adame, A., Fields, J. A., Masliah, D., Iba, M., Lee, H.-J., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0276-2 · Cited by 157
Kannarkat, G. T., Cook, D. A., Lee, J.-K., Chang, J., Chung, J., Sandy, E., Paul, K. C., Ritz, B. R., Bronstein, J. M., Factor, S. A., et al. (2015) · npj Parkinson s Disease · doi:10.1038/npjparkd.2015.2 · Cited by 157
Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo
Kozina, E. A., Sadasivan, S., Jiao, Y., Dou, Y., Ma, Z., Tan, H., Kodali, K., Shaw, T. I., Peng, J., & Smeyne, R. J. (2018) · Brain · doi:10.1093/brain/awy077 · Cited by 155
Drouin-Ouellet, J., St-Amour, I., Saint-Pierre, M., Lamontagne-Proulx, J., Kriz, J., Barker, R. A., & Cicchetti, F. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu103 · Cited by 153
Earls, R. H., Menees, K. B., Chung, J., Barber, J., Gutekunst, C.-A., Hazim, M. G., & Lee, J.-K. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1636-8 · Cited by 151
Earls, R. H., Menees, K. B., Chung, J., Gutekunst, C., Lee, H. J., Hazim, M. G., Rada, B., Wood, L. B., & Lee, J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909110117 · Cited by 151
Chahine, L. M., Qiang, J., Ashbridge, E., Minger, J., Yearout, D., Horn, S., Colcher, A., Hurtig, H. I., Lee, V. M.-Y., Van Deerlin, V. M., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1274 · Cited by 150
Sleep Disturbance as Potential Risk and Progression Factor for Parkinson’s Disease
Bohnen, N. I., & Hu, M. T. M. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191627 · Cited by 149
Prion-Like Mechanisms in Parkinson’s Disease
Ma, J., Gao, J., Wang, J., & Xie, A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00552 · Cited by 145
Emmer, K. L., Waxman, E. A., Covy, J. P., & Giasson, B. I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.247965 · Cited by 144
Alpha‐synuclein in the appendiceal mucosa of neurologically intact subjects
Gray, M. T., Muñoz, D. G., Gray, D. A., Schlossmacher, M. G., & Woulfe, J. (2013) · Movement Disorders · doi:10.1002/mds.25779 · Cited by 144
β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration
Lodygin, D., Hermann, M., Schweingruber, N., Flügel-Koch, C., Watanabe, T., Schlosser, C., Merlini, A., Körner, H., Chang, H.-F., Fischer, H. J., et al. (2019) · Nature · doi:10.1038/s41586-019-0964-2 · Cited by 140
Inflammatory bowel diseases and Parkinson's disease
Brudek, T. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191729 · Cited by 139
Inflammasome and α-synuclein in Parkinson's disease: A cross-sectional study
Chatterjee, K., Roy, A., Banerjee, R., Choudhury, S., Mondal, B., Halder, S., Basu, P., Shubham, S., Dey, S., & Kumar, H. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577089 · Cited by 135
Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
Schröder, J. B., Pawlowski, M., Meyer zu Hörste, G., Gross, C. C., Wiendl, H., Meuth, S. G., Ruck, T., & Warnecke, T. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01081 · Cited by 134
Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease
Agbo, D. B., Wolf, E., Jessen, F., Oechsner, M., Hametner, E., Poewe, W. H., Reindl, M., Oertel, W. H., Noelker, C., Bacher, M., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31827b90d1 · Cited by 133
B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas
Anthony, I., Crawford, D. H., & Bell, J. E. (2003) · Brain · doi:10.1093/brain/awg118 · Cited by 130
Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease
Atashrazm, F., Hammond, D. A., Perera, G., Dobson‐Stone, C., Mueller, N., Pickford, R., Kim, W. S., Kwok, J. B., Lewis, S. J. G., Halliday, G. M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33921-x · Cited by 130
Volpicelli‐Daley, L. A., Kirik, D., Stoyka, L. E., Standaert, D. G., & Harms, A. S. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13627 · Cited by 129
Self-citationPey, P., Pearce, R. K., Kalaitzakis, M. E., Griffin, W. S. T., & Gentleman, S. M. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-21 · Cited by 128
Molecular mechanisms of α-synuclein and GBA1 in Parkinson’s disease
Stojkovska, I., Krainc, D., & Mazzulli, J. R. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2704-y · Cited by 124
Parkinson’s progression prediction using machine learning and serum cytokines
Rastegar, D. A., Ho, N., Halliday, G. M., & Dzamko, N. L. (2019) · npj Parkinson s Disease · doi:10.1038/s41531-019-0086-4 · Cited by 122
Gardai, S. J., Mao, W., Schüle, B., Babcock, M., Schoebel, S., Lorenzana, C., Alexander, J., Kim, S., Glick, H., Hilton, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071634 · Cited by 117
Sánchez-Guajardo, V., Annibali, A., Jensen, P. H., & Romero‐Ramos, M. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31829768d2 · Cited by 117
Self-citationCao, S., Standaert, D. G., & Harms, A. S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-259 · Cited by 115
Self-citationPeripheral blood inflammatory markers in early Parkinson’s disease
Kim, R., Kim, H., Kim, A., Jang, M., Kim, A., Kim, Y. H., Yoo, D., Im, J. H., Choi, J.-H., & Jeon, B. (2018) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2018.10.079 · Cited by 115
Roodveldt, C., Labrador‐Garrido, A., González‐Rey, E., Fernández-Montesinos, R., Caro, M., Lachaud, C. C., Waudby, C. A., Delgado, M., Dobson, C. M., & Pozo, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013481 · Cited by 114
Burbulla, L. F., Jeon, S., Zheng, J., Song, P., Silverman, R. B., & Krainc, D. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau6870 · Cited by 112
Wijeyekoon, R., Kronenberg‐Versteeg, D., Scott, K. M., Hayat, S., Kuan, W., Evans, J., Breen, D. P., Cummins, G. A., Jones, J., Clatworthy, M. R., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.01.018 · Cited by 112
Kim, K. S., Marcogliese, P. C., Yang, J., Callaghan, S. M., Resende, V., Abdel-Messih, E., Marras, C., Visanji, N. P., Huang, J., Schlossmacher, M. G., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718946115 · Cited by 111
Alpha-synuclein activates BV2 microglia dependent on its aggregation state
Hoffmann, A., Ettle, B., Bruno, A., Kulinich, A. O., Hoffmann, A.-C., von Wittgenstein, J., Winkler, J., Xiang, W., & Schlachetzki, J. C. M. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.109 · Cited by 111
Shaik, S., Combs, C. K., & Ebadi, M. (2006) · Neurochemical Research · doi:10.1007/s11064-005-9233-x · Cited by 109
Tentillier, N., Etzerodt, A., Olesen, M. N., Rizalar, F. S., Jacobsen, J., Bender, D., Moestrup, S. K., & Romero-Ramos, M. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1636-16.2016 · Cited by 109
Self-citationWilliams, G. P., Schonhoff, A. M., Jurkuvenaite, A., Thome, A. D., Standaert, D. G., & Harms, A. S. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1286-2 · Cited by 105
Self-citationAlterations in Blood Monocyte Functions in Parkinson's Disease
Nissen, S. K., Shrivastava, K., Schulte, C., Otzen, D. E., Goldeck, D., Berg, D., Møller, H. J., Maetzler, W., & Romero‐Ramos, M. (2019) · Movement Disorders · doi:10.1002/mds.27815 · Cited by 101
Self-citationHou, L., Bao, X., Zang, C., Yang, H., Sun, F., Che, Y., Wu, X., Li, S., Zhang, D., & Wang, Q. (2018) · Redox Biology · doi:10.1016/j.redox.2017.11.010 · Cited by 98
Microglial modulation of neuronal activity in the healthy brain
York, E. M., Bernier, L., & MacVicar, B. A. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22571 · Cited by 98
FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis
Choi, Y. R., Kang, S., Kim, J.-M., Lee, S., Jou, I., Joe, E.-H., & Park, S. M. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.025 · Cited by 98
Increased peripheral inflammation in asymptomatic leucine‐rich repeat kinase 2 mutation carriers
Dzamko, N., Rowe, D. B., & Halliday, G. M. (2016) · Movement Disorders · doi:10.1002/mds.26529 · Cited by 98
Venezia, S., Refolo, V., Polissidis, A., Stefanis, L., Wenning, G. K., & Stefanova, N. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0195-7 · Cited by 97
Cao, S., Theodore, S., & Standaert, D. G. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-42 · Cited by 95
Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
Santaella, A., Kuiperij, H. B., van Rumund, A., Esselink, R. A. J., van Gool, A. J., Bloem, B. R., & Verbeek, M. M. (2020) · BMC Neurology · doi:10.1186/s12883-020-1608-8 · Cited by 91
Protective features of peripheral monocytes/macrophages in stroke
Gliem, M., Schwaninger, M., & Jander, S. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.11.004 · Cited by 88
O’Donovan, S. M., Crowley, E. K., Brown, J. R. ‐., O’Sullivan, O., O’Leary, O. F., Timmons, S., Nolan, Y. M., Clarke, D. J., Hyland, N. P., Joyce, S. A., et al. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13726 · Cited by 86
Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease
Funk, N., Wieghofer, P., Grimm, S., Schäfer, R., Bühring, H., Gasser, T., & Biskup, S. (2013) · Movement Disorders · doi:10.1002/mds.25300 · Cited by 85
Rivero-Ríos, P., Romo-Lozano, M., Madero-Pérez, J., Thomas, A. P., Biosa, A., Greggio, E., & Hilfiker, S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005008 · Cited by 83
Mullin, S., Stokholm, M. G., Hughes, D. A., Mehta, A. B., Parbo, P., Hinz, R., Pavese, N., Brooks, D. J., & Schapira, A. H. V. (2019) · Movement Disorders · doi:10.1002/mds.28375 · Cited by 81
Gündner, A. L., Durán-Pacheco, G., Zimmermann, S., Ruf, I., Moors, T. E., Baumann, K., Jagasia, R., van de Berg, W. D. J., & Kremer, T. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.09.015 · Cited by 78
Bussi, C., Ramos, J. M. P., Arroyo, D. S., Gallea, J. I., Ronchi, P., Kolovou, A., Wang, J. M., Florey, O., Celej, M. S., Schwab, Y., et al. (2018) · Journal of Cell Science · doi:10.1242/jcs.226241 · Cited by 78
Multiple-Hit Hypothesis in Parkinson’s Disease: LRRK2 and Inflammation
Cabezudo, D., Baekelandt, V., & Lobbestael, E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00376 · Cited by 78
Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates
Barkholt, P., Sánchez-Guajardo, V., Kirik, D., & Romero‐Ramos, M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.004 · Cited by 77
Self-citationImmune cell subtyping in the cerebrospinal fluid of patients with neurological diseases
Kowarik, M. C., Grummel, V., Wemlinger, S. M., Buck, D., Weber, M. S., Berthele, A., & Hemmer, B. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7145-2 · Cited by 75
Svensson, E., Horváth–Puhó, E., Stokholm, M. G., Sørensen, H. T., Henderson, V. W., & Borghammer, P. (2016) · Movement Disorders · doi:10.1002/mds.26761 · Cited by 75
Rydbirk, R., Elfving, B., Andersen, M. D., Langbøl, M. A., Folke, J., Winge, K., Pakkenberg, B., Brudek, T., & Aznar, S. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.014 · Cited by 74
Horváth, I., Iashchishyn, I. A., Forsgren, L., & Morozova‐Roche, L. A. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00063 · Cited by 69
Al‐Qassabi, A., Tsao, T., Racolta, A., Kremer, T., Cañamero, M., Belousov, A., Santana, M. A., Beck, R. C., Zhang, H., Meridew, J. A., et al. (2020) · Movement Disorders · doi:10.1002/mds.28399 · Cited by 67
β1-integrin-dependent migration of microglia in response to neuron-released α-synuclein
Kim, C., Cho, E.-D., Kim, H.-K., You, S., Lee, H.-J., Hwang, D., & Lee, S. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.6 · Cited by 66
A monocyte gene expression signature in the early clinical course of Parkinson’s disease
Schlachetzki, J. C. M., Prots, I., Tao, J., Chun, H. B., Saijo, K., Gosselin, D., Winner, B., Glass, C. K., & Winkler, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-28986-7 · Cited by 65
Filippini, A., Gennarelli, M., & Russo, I. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00649-9 · Cited by 65
Brudek, T., Winge, K., Folke, J., Christensen, S., Fog, K., Pakkenberg, B., & Pedersen, L. Ø. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0187-7 · Cited by 64
A Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's Disease
Scott, K. M., Kouli, A., Yeoh, S. L., Clatworthy, M. R., & Williams‐Gray, C. H. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00815 · Cited by 64
Ramos, J. M. P., Iribarren, P., Bousset, L., Melki, R., Baekelandt, V., & der Perren, A. V. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00080 · Cited by 64
Baseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease
Sawada, H., Oeda, T., Umemura, A., Tomita, S., Kohsaka, M., Park, K., Yamamoto, K., & Sugiyama, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134118 · Cited by 63
Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease
Nissen, S. K., Ferreira, S. A., Nielsen, M. C., Schulte, C., Shrivastava, K., Hennig, D., Etzerodt, A., Graversen, J. H., Berg, D., Maetzler, W., et al. (2020) · Movement Disorders · doi:10.1002/mds.28424 · Cited by 63
Self-citationThe Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease
White, A. J., Wijeyekoon, R., Scott, K. M., Gunawardana, N. P., Hayat, S., Solim, I. H., McMahon, H. T., Barker, R. A., & Williams‐Gray, C. H. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00946 · Cited by 62
Akhtar, R. S., Licata, J. P., Luk, K. C., Shaw, L. M., Trojanowski, J. Q., & Lee, V. M. ‐. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14330 · Cited by 60
Martinez, E. M., Young, A. L., Patankar, Y. R., Berwin, B. L., Wang, L., von Herrmann, K. M., Weier, J. M., & Havrda, M. C. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx117 · Cited by 59
Identification of the amino acid sequence motif of α-synuclein responsible for macrophage activation
Lee, S.-B., Park, S. M., Ahn, K. J., Chung, K. C., Paik, S. R., & Kim, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.002 · Cited by 58
Inflammatory profile discriminates clinical subtypes in LRRK2‐associated Parkinson's disease
Brockmann, K., Schulte, C., Schneiderhan‐Marra, N., Apel, A., Pont‐Sunyer, C., Vilas, D., Ruiz‐Martínez, J., Langkamp, M., Corvol, J., Cormier‐Dequaire, F., et al. (2017) · European Journal of Neurology · doi:10.1111/ene.13223 · Cited by 58
Shalash, A., Salama, M., Makar, M., Roushdy, T., Elrassas, H. H., Mohamed, W., El-Balkimy, M., & Abou Donia, M. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00720 · Cited by 58
Dhillon, J.-K. S., Trejo‐Lopez, J. A., Riffe, C. J., Levites, Y., Sacino, A. N., Borchelt, D., Yachnis, A. T., & Giasson, B. I. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0733-3 · Cited by 51
Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on Phagocytosis
Wijeyekoon, R. S., Kronenberg-Versteeg, D., Scott, K. M., Hayat, S., Jones, J. L., Clatworthy, M. R., Floto, R. A., Barker, R. A., & Williams-Gray, C. H. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00870 · Cited by 50
Pinho, R., Guedes, L. C., Soreq, L., Lobo, P. P., Mestre, T., Coelho, M. M., Rosa, M. M., Gonçalves, N., Wales, P., Mendes, T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157852 · Cited by 50
Li, F., Ayaki, T., Maki, T., Sawamoto, N., & Takahashi, R. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly090 · Cited by 44
Gustafsson, G., Eriksson, F., Möller, C., da Fonseca, T. L., Outeiro, T. F., Lannfelt, L., Bergström, J. J. E., & Ingelsson, M. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0352-5 · Cited by 40
Christiansen, J. R., Olesen, M. N., Otzen, D. E., Romero‐Ramos, M., & Sánchez-Guajardo, V. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0532-8 · Cited by 40
Self-citationSystemic Inflammation in Lewy Body Diseases: A Systematic Review
King, E., & Thomas, A. J. (2017) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000211 · Cited by 39
Zhang, W., Gao, J.-H., Yan, Z.-F., Huang, X.-Y., Guo, P., Sun, L., Liu, Z., Hu, Y., Zuo, L.-J., Yu, S.-Y., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-016-0308-2 · Cited by 37
Juul‐Madsen, K., Qvist, P., Bendtsen, K. L., Langkilde, A. E., Vestergaard, B., Howard, K. A., Dehesa-Etxebeste, M., Paludan, S. R., Andersen, G. R., Jensen, P. H., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900494 · Cited by 37
Self-citationInteraction of LRRK2 and α-Synuclein in Parkinson’s Disease
Daher, J. P. L. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-49969-7_11 · Cited by 33
Olesen, M. N., Christiansen, J. R., Petersen, S. V., Jensen, P. H., Pasławski, W., Romero‐Ramos, M., & Sánchez-Guajardo, V. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00513 · Cited by 28
Self-citationPeripheral Blood Inflammatory Cytokines in Idiopathic REM Sleep Behavior Disorder
Kim, R., Jun, J., Kim, H., Jung, K., Shin, Y., Yang, T., Kim, K. T., Kim, T., Byun, J., Sunwoo, J., et al. (2019) · Movement Disorders · doi:10.1002/mds.27841 · Cited by 26
Monocytes and Parkinson's Disease: Invaders From Outside?
Harms, A. S., & Standaert, D. G. (2014) · Movement Disorders · doi:10.1002/mds.25993 · Cited by 7
Self-citation
Cited by
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
“226 Monocytes and macrophages have been found to in fi ltrate the in fl amed brain.”
BackgroundInflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
Microglia Mediated Neuroinflammation in Parkinson’s Disease
Isik, S., Yeman Kiyak, B., Akbayir, R., Seyhali, R., & Arpaci, T. (2023) · Cells · doi:10.3390/cells12071012 · Cited by 379
Gut liver brain axis in diseases: the implications for therapeutic interventions
Yan, M., Man, S., Sun, B., Ma, L., Guo, L., Huang, L., & Gao, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01673-4 · Cited by 287
Kou, L., Chi, X., Sun, Y., Han, C., Wan, F., Hu, J., Yin, S., Wu, J., Li, Y., Zhou, Q., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02494-y · Cited by 109
Metadata
- Authors
- Harms, A. S., Ferreira, S. A., & Romero-Ramos, M.
- Venue
- Acta Neuropathologica
- Published
- 2021-02-08
- Volume
- 141
- Issue
- 4
- Pages
- 527-545
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W3126400801
- Cited by
- 272
- References
- 195
- FWCI
- 19.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.